Clinical Trial Details

EORTC-26081

Back to Clinical Trials Database

Phase III Intergroup Study of Radiotherapy with Concomitant and Adjuvant Temozolomide versus Radiotherapy with Adjuvant PCV Chemotherapy in Patients with 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma

Study documentation

Trial Status All trial activities ended
Dates Date of activation: 22-Dec-2010
Data management at EORTC No
Design Phase 3
Randomized open label
Targeted Sample size EORTC Groups: 200 - All Groups: 585
Treatment
Study Staff
Type of cancer
Participating groups
Protocol summary http://clinicaltrials.gov/study/NCT00887146
NCT number NCT00887146
EudraCT 2008-007295-14